Inactivation of Prostaglandin E2 as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia.
Front Oncol
; 9: 606, 2019.
Article
in En
| MEDLINE
| ID: mdl-31334126
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Front Oncol
Year:
2019
Document type:
Article
Affiliation country:
Canadá